Skip to Main content Skip to Navigation
Conference papers

Natalizumab alters the TCR repertoire after one year of treatment in four MS patients

Laure Michel 1, 2 Marion Salou 1 Alexandra Garcia 1 Nicolas Degauque 1 Anne Salmon 1 Annie Ngono 1 Arnaud Nicot 1 Sandrine Wiertlewski 2 Jean-Paul Soulillou 1 Sophie Brouard 1 David Laplaud 1, 2
1 Immunointervention dans les allo et xénotransplantations
2 Service de neurologie [Nantes]
Résumé : n.a
Document type :
Conference papers
Complete list of metadata
https://www.hal.inserm.fr/inserm-00643971
Contributor : Ed. Bmc Connect in order to contact the contributor
Submitted on : Wednesday, November 23, 2011 - 1:08:13 PM
Last modification on : Thursday, July 29, 2021 - 2:32:06 PM
Long-term archiving on: : Friday, February 24, 2012 - 2:28:50 AM

Files

Vignette du document
1479-5876-9-S2-P26.pdf
Publisher files allowed on an open archive

Identifiers

  • HAL Id : inserm-00643971, version 1

Collections

INSERM | UNIV-NANTES

Citation

Laure Michel, Marion Salou, Alexandra Garcia, Nicolas Degauque, Anne Salmon, et al.. Natalizumab alters the TCR repertoire after one year of treatment in four MS patients. 6th european workshop on immune-mediated inflammatory diseases, Nice, France. pp.P26. ⟨inserm-00643971⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

246

Files downloads

466